An Open, Randomized Study, to Investigate the Potential Food Effect on Pharmacokinetic Parameters of ABX464 Administered Orally to Healthy Male Subjects
Latest Information Update: 18 Nov 2016
Price :
$35 *
At a glance
- Drugs Obefazimod (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Abivax
- 31 Oct 2016 Results assessing food effect on pharmacokinetic parameters of ABX464 published in the Antimicrobial Agents and Chemotherapy
- 11 Apr 2016 New trial record